| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Inhibits Signaling by Mitogen-Activated Protein Kinases1
Departments of 1 Molecular Genetics and 2 Biological Regulation, The Weizmann Institute of Science, Rehovot, Israel
Requests for reprints: Ari Elson, Department of Molecular Genetics, The Weizmann Institute of Science, Rehovot 76100, Israel. Phone: 972-8-934-2331; Fax: 972-8-934-4108. E-mail: ari.elson{at}weizmann.ac.il
Mitogen-activated protein kinases (MAPKs) mediate signaling from the cell membrane to the nucleus following their phosphorylation at conserved threonine and tyrosine residues within their activation loops. We show that protein tyrosine phosphatase 
(PTP) inhibits ERK1 and ERK2 kinase activity and reduces their phosphorylation; in agreement, ERK phosphorylation is increased in fibroblasts and in mammary tumor cells from mice genetically lacking PTP. PTP inhibits events downstream of ERKs, such as transcriptional activation mediated by Elk1 or by the serum response element. PTP also inhibits transcriptional activation mediated by c-Jun and C/EBP binding protein (CHOP) but not that mediated by the unrelated NFkB, attesting that it is broadly active within the MAPK family but otherwise specific. The effect of PTP on ERKs is at least in part indirect because phosphorylation of the threonine residue in the ERK activation loop is reduced in the presence of PTP. Nonetheless, PTP is present in a molecular complex with ERK, providing PTP with opportunity to act on ERK proteins also directly. We conclude that PTP is a physiological inhibitor of ERK signaling. Slow induction of PTP and its lack of nuclear translocation following mitogenic stimulation suggest that PTP functions to prevent inappropriate activation and to terminate prolonged, rather than acute, activation of ERK in the cytosol.
This article has been cited by other articles:
|
|
 |
|
  M. R. Junttila, S.-P. Li, and J. Westermarck Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival FASEB J, April 1, 2008; 22(4): 954 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Kraut-Cohen, W. J. Muller, and A. Elson Protein-tyrosine Phosphatase {epsilon} Regulates Shc Signaling in a Kinase-specific Manner: INCREASING COHERENCE IN TYROSINE PHOSPHATASE SIGNALING J. Biol. Chem., February 22, 2008; 283(8): 4612 - 4621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Aga-Mizrachi, T. Brutman-Barazani, A. I. Jacob, A. Bak, A. Elson, and S. R. Sampson Cytosolic Protein Tyrosine Phosphatase-{epsilon} Is a Negative Regulator of Insulin Signaling in Skeletal Muscle Endocrinology, February 1, 2008; 149(2): 605 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Sines, S. Granot-Attas, S. Weisman-Welcher, and A. Elson Association of Tyrosine Phosphatase Epsilon with Microtubules Inhibits Phosphatase Activity and Is Regulated by the Epidermal Growth Factor Receptor Mol. Cell. Biol., October 15, 2007; 27(20): 7102 - 7112. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Tiran, A. Peretz, T. Sines, V. Shinder, J. Sap, B. Attali, and A. Elson Tyrosine Phosphatases {varepsilon} and {alpha} Perform Specific and Overlapping Functions in Regulation of Voltage-gated Potassium Channels in Schwann Cells Mol. Biol. Cell, October 1, 2006; 17(10): 4330 - 4342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Chiusaroli, H. Knobler, C. Luxenburg, A. Sanjay, S. Granot-Attas, Z. Tiran, T. Miyazaki, A. Harmelin, R. Baron, and A. Elson Tyrosine Phosphatase Epsilon Is a Positive Regulator of Osteoclast Function in Vitro and In Vivo Mol. Biol. Cell, January 1, 2004; 15(1): 234 - 244. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |
